Regen BioPharma Inc SEC filings RGBP

Regen BioPharma Inc has 263 filings in SEC EDGAR's recent list, going back to Oct 15, 2013. Its latest annual report, Form 10-K, was filed on Dec 30, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement). The company's fiscal year ends on September 30.

Form Description Filed Period
10-K Annual report Dec 30, 2025 Sep 30, 2025
10-K Annual report May 13, 2025 Sep 30, 2024
10-K Annual report Nov 20, 2023 Sep 30, 2023
10-K Annual report Nov 15, 2022 Sep 30, 2022
10-K Annual report Dec 22, 2021 Sep 30, 2021
10-K Annual report Aug 4, 2021 Sep 30, 2020
10-K Annual report Jun 21, 2021 Sep 30, 2019
10-K Annual report Dec 27, 2018 Sep 30, 2018
10-K Annual report Jan 5, 2018 Sep 30, 2017
10-K/A Amended annual report Apr 28, 2017 Sep 30, 2016
10-K/A Amended annual report Apr 28, 2017 Sep 30, 2015
10-K/A Amended annual report Mar 30, 2017 Sep 30, 2016
10-K/A Amended annual report Mar 30, 2017 Sep 30, 2015
10-K Annual report Dec 21, 2016 Sep 30, 2016
10-K Annual report Jan 7, 2016 Sep 30, 2015
10-K/A Amended annual report Dec 22, 2014 Sep 30, 2014
10-K Annual report Dec 18, 2014 Sep 30, 2014

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RGBP (OTC), RGBPP (OTC)
Fiscal year ends
September 30
Incorporated in
NV
Headquarters
La Mesa, CA
SEC filer status
, Emerging growth company
SEC CIK
1589150

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.